Note: Ingredients listed on restricted chemical lists
General Information
Version
1.0
Revision date
2019-10-29
Product name
Viramune tablets (finished product)
Product Synonyms
Viramune® 50mg tablets, Viramune® 200mg tablets, Vira- mune® 400mg tablets, Viramune® XR 50 mg tablets, Vira- mune® XR 100 mg tablets, Viramune® XR 400 mg tablets. Active ingredient: Nevirapine
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ingelheim Vetmedica
Icons in SDS
Company Information
company name
Boehringer Ingelheim Vetmedica
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) GHS classification in accordance with
Signal word
Warning
Hazard statements
H302 Harmful if swallowed.
Prevention
P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
